[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fL9HVEnlstHSr4WwAmLFPAoR7D9WvKtp7VfRhfrMNGV4":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":44,"rows":51},"Universidad de Granada",[4],239,false,37,6,76002,4,226,[14,17,20,22,24,27,29,31],{"name":15,"count":16},"Fibromyalgia",16,{"name":18,"count":19},"Breast Cancer",7,{"name":21,"count":9},"Obesity",{"name":23,"count":9},"Healthy",{"name":25,"count":26},"Chronic Obstructive Pulmonary Disease",5,{"name":28,"count":26},"Stroke",{"name":30,"count":11},"Sinus Floor Augmentation",{"name":32,"count":11},"COPD",[34,39],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT07031778","Topic Simvastatin for Bone Regeneration","2025-01-07","Simvastatin",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT06664060","Osteoimplant and Bone Healing","2025-12-31","osteoimplant",[45,46,47,48,49,50],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[52,78,96,114,134,160,178,203,230,257,275,304,322,349,374,396,422,447],{"intervention":38,"totalTrials":53,"cells":54},1,{"EARLY_PHASE1":55,"PHASE1":67,"PHASE2":70,"PHASE3":72,"PHASE4":74,"NA":76},{"trials":56,"activeCount":53,"soonestReadout":37},[57],{"nctId":35,"briefTitle":36,"status":58,"phases":59,"primaryCompletion":37,"completion":42,"start":37,"enrollment":60,"conditions":61,"interventions":64},"RECRUITING",[45],90,[62,63],"Dimensional Changes","Bone Density",[38,65,66],"Simvastatin 10 mg","Simvastatin Placebo",{"trials":68,"activeCount":69},[],0,{"trials":71,"activeCount":69},[],{"trials":73,"activeCount":69},[],{"trials":75,"activeCount":69},[],{"trials":77,"activeCount":69},[],{"intervention":65,"totalTrials":53,"cells":79},{"EARLY_PHASE1":80,"PHASE1":86,"PHASE2":88,"PHASE3":90,"PHASE4":92,"NA":94},{"trials":81,"activeCount":53,"soonestReadout":37},[82],{"nctId":35,"briefTitle":36,"status":58,"phases":83,"primaryCompletion":37,"completion":42,"start":37,"enrollment":60,"conditions":84,"interventions":85},[45],[62,63],[38,65,66],{"trials":87,"activeCount":69},[],{"trials":89,"activeCount":69},[],{"trials":91,"activeCount":69},[],{"trials":93,"activeCount":69},[],{"trials":95,"activeCount":69},[],{"intervention":66,"totalTrials":53,"cells":97},{"EARLY_PHASE1":98,"PHASE1":104,"PHASE2":106,"PHASE3":108,"PHASE4":110,"NA":112},{"trials":99,"activeCount":53,"soonestReadout":37},[100],{"nctId":35,"briefTitle":36,"status":58,"phases":101,"primaryCompletion":37,"completion":42,"start":37,"enrollment":60,"conditions":102,"interventions":103},[45],[62,63],[38,65,66],{"trials":105,"activeCount":69},[],{"trials":107,"activeCount":69},[],{"trials":109,"activeCount":69},[],{"trials":111,"activeCount":69},[],{"trials":113,"activeCount":69},[],{"intervention":43,"totalTrials":53,"cells":115},{"EARLY_PHASE1":116,"PHASE1":124,"PHASE2":126,"PHASE3":128,"PHASE4":130,"NA":132},{"trials":117,"activeCount":53,"soonestReadout":42},[118],{"nctId":40,"briefTitle":41,"status":119,"phases":120,"primaryCompletion":42,"completion":42,"start":37,"enrollment":121,"conditions":122,"interventions":123},"NOT_YET_RECRUITING",[45],60,[62,63],[43],{"trials":125,"activeCount":69},[],{"trials":127,"activeCount":69},[],{"trials":129,"activeCount":69},[],{"trials":131,"activeCount":69},[],{"trials":133,"activeCount":69},[],{"intervention":135,"totalTrials":53,"cells":136},"amitriptyline",{"EARLY_PHASE1":137,"PHASE1":139,"PHASE2":141,"PHASE3":143,"PHASE4":145,"NA":158},{"trials":138,"activeCount":69},[],{"trials":140,"activeCount":69},[],{"trials":142,"activeCount":69},[],{"trials":144,"activeCount":69},[],{"trials":146,"activeCount":69},[147],{"nctId":148,"briefTitle":149,"status":150,"phases":151,"primaryCompletion":152,"completion":153,"start":154,"enrollment":60,"conditions":155,"interventions":156},"NCT00766350","Comparative Efficacy and Tolerability of Quetiapine XR and Amitriptyline in the Treatment of Fibromyalgia","COMPLETED",[49],"2010-03","2010-10","2008-11",[15],[135,157],"quetiapine",{"trials":159,"activeCount":69},[],{"intervention":157,"totalTrials":53,"cells":161},{"EARLY_PHASE1":162,"PHASE1":164,"PHASE2":166,"PHASE3":168,"PHASE4":170,"NA":176},{"trials":163,"activeCount":69},[],{"trials":165,"activeCount":69},[],{"trials":167,"activeCount":69},[],{"trials":169,"activeCount":69},[],{"trials":171,"activeCount":69},[172],{"nctId":148,"briefTitle":149,"status":150,"phases":173,"primaryCompletion":152,"completion":153,"start":154,"enrollment":60,"conditions":174,"interventions":175},[49],[15],[135,157],{"trials":177,"activeCount":69},[],{"intervention":179,"totalTrials":53,"cells":180},"trazodone, pregabalin",{"EARLY_PHASE1":181,"PHASE1":183,"PHASE2":185,"PHASE3":187,"PHASE4":189,"NA":201},{"trials":182,"activeCount":69},[],{"trials":184,"activeCount":69},[],{"trials":186,"activeCount":69},[],{"trials":188,"activeCount":69},[],{"trials":190,"activeCount":69},[191],{"nctId":192,"briefTitle":193,"status":150,"phases":194,"primaryCompletion":195,"completion":196,"start":197,"enrollment":198,"conditions":199,"interventions":200},"NCT00791739","Trazodone and Its Augmentation With Pregabalin in the Treatment of Fibromyalgia",[49],"2009-07","2009-10","2008-04",66,[15],[179],{"trials":202,"activeCount":69},[],{"intervention":204,"totalTrials":53,"cells":205},"GTO®",{"EARLY_PHASE1":206,"PHASE1":208,"PHASE2":210,"PHASE3":212,"PHASE4":214,"NA":228},{"trials":207,"activeCount":69},[],{"trials":209,"activeCount":69},[],{"trials":211,"activeCount":69},[],{"trials":213,"activeCount":69},[],{"trials":215,"activeCount":69},[216],{"nctId":217,"briefTitle":218,"status":219,"phases":220,"primaryCompletion":221,"completion":222,"start":223,"enrollment":224,"conditions":225,"interventions":227},"NCT06378112","Extraction Socket Augmentation. A Clinical Study","UNKNOWN",[49],"2025-01-15","2025-12-30","2022-05-20",40,[226],"Edentulous Alveolar Ridge With Labial Resorption",[204],{"trials":229,"activeCount":69},[],{"intervention":231,"totalTrials":53,"cells":232},"Hyaluronic Acid",{"EARLY_PHASE1":233,"PHASE1":235,"PHASE2":237,"PHASE3":239,"PHASE4":241,"NA":255},{"trials":234,"activeCount":69},[],{"trials":236,"activeCount":69},[],{"trials":238,"activeCount":69},[],{"trials":240,"activeCount":69},[],{"trials":242,"activeCount":69},[243],{"nctId":244,"briefTitle":245,"status":150,"phases":246,"primaryCompletion":247,"completion":248,"start":249,"enrollment":250,"conditions":251,"interventions":253},"NCT03157193","Effect of Hyaluronic Acid on Perimplantitis",[49],"2016-01","2016-12","2014-09",61,[252],"Peri-Implantitis",[231,254],"Hydroxypropyl Guar",{"trials":256,"activeCount":69},[],{"intervention":254,"totalTrials":53,"cells":258},{"EARLY_PHASE1":259,"PHASE1":261,"PHASE2":263,"PHASE3":265,"PHASE4":267,"NA":273},{"trials":260,"activeCount":69},[],{"trials":262,"activeCount":69},[],{"trials":264,"activeCount":69},[],{"trials":266,"activeCount":69},[],{"trials":268,"activeCount":69},[269],{"nctId":244,"briefTitle":245,"status":150,"phases":270,"primaryCompletion":247,"completion":248,"start":249,"enrollment":250,"conditions":271,"interventions":272},[49],[252],[231,254],{"trials":274,"activeCount":69},[],{"intervention":276,"totalTrials":53,"cells":277},"Dexamethasone 4 Mg\u002FmL Injectable Solution",{"EARLY_PHASE1":278,"PHASE1":280,"PHASE2":282,"PHASE3":284,"PHASE4":300,"NA":302},{"trials":279,"activeCount":69},[],{"trials":281,"activeCount":69},[],{"trials":283,"activeCount":69},[],{"trials":285,"activeCount":69},[286],{"nctId":287,"briefTitle":288,"status":150,"phases":289,"primaryCompletion":290,"completion":291,"start":292,"enrollment":293,"conditions":294,"interventions":298},"NCT05752305","Use of Corticosteroids in Third Molar Surgery",[47,48],"2023-07-01","2023-07-15","2022-01-15",84,[295,296,297],"Inflammation","Pain, Postoperative","Trismus",[276,299],"MethylPREDNISolone 40 Mg\u002FmL Injectable Suspension",{"trials":301,"activeCount":69},[],{"trials":303,"activeCount":69},[],{"intervention":299,"totalTrials":53,"cells":305},{"EARLY_PHASE1":306,"PHASE1":308,"PHASE2":310,"PHASE3":312,"PHASE4":318,"NA":320},{"trials":307,"activeCount":69},[],{"trials":309,"activeCount":69},[],{"trials":311,"activeCount":69},[],{"trials":313,"activeCount":69},[314],{"nctId":287,"briefTitle":288,"status":150,"phases":315,"primaryCompletion":290,"completion":291,"start":292,"enrollment":293,"conditions":316,"interventions":317},[47,48],[295,296,297],[276,299],{"trials":319,"activeCount":69},[],{"trials":321,"activeCount":69},[],{"intervention":323,"totalTrials":53,"cells":324},"Malic Acid",{"EARLY_PHASE1":325,"PHASE1":327,"PHASE2":329,"PHASE3":331,"PHASE4":345,"NA":347},{"trials":326,"activeCount":69},[],{"trials":328,"activeCount":69},[],{"trials":330,"activeCount":69},[],{"trials":332,"activeCount":69},[333],{"nctId":334,"briefTitle":335,"status":150,"phases":336,"primaryCompletion":337,"completion":337,"start":338,"enrollment":339,"conditions":340,"interventions":344},"NCT01652001","Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity",[47,48],"2014-01","2011-01",185,[341,342,343],"Xerostomia","Depression","Hypertension",[323],{"trials":346,"activeCount":69},[],{"trials":348,"activeCount":69},[],{"intervention":350,"totalTrials":53,"cells":351},"cephalosporin with or without erythromycin",{"EARLY_PHASE1":352,"PHASE1":354,"PHASE2":356,"PHASE3":358,"PHASE4":360,"NA":362},{"trials":353,"activeCount":69},[],{"trials":355,"activeCount":69},[],{"trials":357,"activeCount":69},[],{"trials":359,"activeCount":69},[],{"trials":361,"activeCount":69},[],{"trials":363,"activeCount":69},[364],{"nctId":365,"briefTitle":366,"status":219,"phases":367,"primaryCompletion":368,"completion":369,"start":370,"enrollment":121,"conditions":371,"interventions":373},"NCT02515565","Physiotherapy in Patients Hospitalized Due to Pneumonia.",[50],"2018-04","2018-07","2015-09",[372],"Pneumonia",[350],{"intervention":375,"totalTrials":53,"cells":376},"Medical standard treatment",{"EARLY_PHASE1":377,"PHASE1":379,"PHASE2":381,"PHASE3":383,"PHASE4":385,"NA":387},{"trials":378,"activeCount":69},[],{"trials":380,"activeCount":69},[],{"trials":382,"activeCount":69},[],{"trials":384,"activeCount":69},[],{"trials":386,"activeCount":69},[],{"trials":388,"activeCount":69},[389],{"nctId":390,"briefTitle":391,"status":219,"phases":392,"primaryCompletion":393,"completion":369,"start":370,"enrollment":121,"conditions":394,"interventions":395},"NCT02515318","Physiotherapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease",[50],"2017-03",[32],[375],{"intervention":397,"totalTrials":53,"cells":398},"agomelatine",{"EARLY_PHASE1":399,"PHASE1":401,"PHASE2":403,"PHASE3":405,"PHASE4":407,"NA":409},{"trials":400,"activeCount":69},[],{"trials":402,"activeCount":69},[],{"trials":404,"activeCount":69},[],{"trials":406,"activeCount":69},[],{"trials":408,"activeCount":69},[],{"trials":410,"activeCount":69},[411],{"nctId":412,"briefTitle":413,"status":150,"phases":414,"primaryCompletion":415,"completion":416,"start":417,"enrollment":418,"conditions":419,"interventions":421},"NCT01731899","Agomelatine in Depressed Patients With Fibromyalgia",[],"2012-10","2012-11","2010-06",27,[420,15],"Major Depression",[397],{"intervention":423,"totalTrials":53,"cells":424},"Standard medical treatment",{"EARLY_PHASE1":425,"PHASE1":427,"PHASE2":429,"PHASE3":431,"PHASE4":433,"NA":435},{"trials":426,"activeCount":69},[],{"trials":428,"activeCount":69},[],{"trials":430,"activeCount":69},[],{"trials":432,"activeCount":69},[],{"trials":434,"activeCount":69},[],{"trials":436,"activeCount":69},[437],{"nctId":438,"briefTitle":439,"status":150,"phases":440,"primaryCompletion":441,"completion":442,"start":443,"enrollment":444,"conditions":445,"interventions":446},"NCT02509299","Effect of Physiotherapy in Hospitalized COPD Patients",[50],"2019-11-20","2019-12-14","2019-09-01",49,[32],[423],{"intervention":448,"totalTrials":53,"cells":449},"Psychopharmacology intervention",{"EARLY_PHASE1":450,"PHASE1":452,"PHASE2":454,"PHASE3":456,"PHASE4":458,"NA":460},{"trials":451,"activeCount":69},[],{"trials":453,"activeCount":69},[],{"trials":455,"activeCount":69},[],{"trials":457,"activeCount":69},[],{"trials":459,"activeCount":69},[],{"trials":461,"activeCount":69},[462],{"nctId":463,"briefTitle":464,"status":150,"phases":465,"primaryCompletion":466,"completion":466,"start":467,"enrollment":121,"conditions":468,"interventions":471},"NCT04272541","Effectiveness of a Psychoeducation Program in Patients With Severe Mental Disorder",[50],"2020-11-20","2020-02-20",[469,470],"Mental Health Disorder","Healthy Lifestyle",[448]]